Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
45,496,681
-
Shares change
-
+3,254,979
-
Total reported value, excl. options
-
$7,835,602,804
-
Value change
-
+$598,946,530
-
Put/Call ratio
-
258%
-
Number of buys
-
84
-
Number of sells
-
56
-
Price
-
$172.22
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q3 2018
As of 30 Sep 2018 BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) had 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 45,496,681 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, Hillhouse Capital Management, Ltd., FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, HSBC HOLDINGS PLC, Temasek Holdings (Private) Ltd, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, CANADA PENSION PLAN INVESTMENT BOARD, and Vanguard Group Inc.
This table shows 178 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.